Form 4: CarMax CEO William Nash Reports Stock Option Grant
SEC Form 4 Filing
William Nash, President & CEO of CarMax, reports the acquisition of stock options on May 1, 2024.
Summary
- William Nash, the President & CEO of CarMax, filed a Form 4 on May 3, 2024, reporting a transaction.
- On May 1, 2024, Nash acquired 179,918 stock options with an exercise price of $67.21.
- These options become exercisable in four equal installments on May 1st of 2025, 2026, 2027, and 2028.
- The stock options were granted in tandem with stock appreciation rights (SARS), where exercising one results in surrendering the other.
- The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated.
- Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options.
- Following the reported transaction, Nash directly owns 179,918 derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, so the sentiment is neutral.
Positives
- The grant of stock options to the CEO aligns his interests with those of the shareholders, incentivizing him to improve the company's performance.
Industry Context
Stock option grants are a common form of executive compensation in the automotive retail industry, aligning management's interests with shareholder value.
Comparison to Industry Standards
- Comparing CarMax's executive compensation structure to peers like AutoNation or Group 1 Automotive would provide a benchmark for assessing the size and vesting schedule of these stock options.
- Typically, executive compensation packages include a mix of base salary, bonus, and equity-based compensation, with the proportion of each varying based on company size, performance, and industry norms.
- Vesting schedules for stock options often range from three to five years, aligning with long-term value creation.
Stakeholder Impact
- The stock option grant could positively impact shareholders by incentivizing the CEO to improve company performance.
- Employees may view the grant as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 05/01/2024 | Date of stock option grant and SARS grant |
| 05/01/2025 | First vesting date for one-fourth of the stock options |
| 05/01/2026 | Second vesting date for one-fourth of the stock options |
| 05/01/2027 | Third vesting date for one-fourth of the stock options |
| 05/01/2028 | Fourth vesting date for one-fourth of the stock options |
| 05/01/2031 | Expiration date of the stock options |
| 05/03/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.